PharmacovigilanceOfficial

CMS finalises CY 2027 Home Health rule with Medicare payment recovery changes

🇺🇸 CMS · Wed 04 Nov 2026

The US agency says the final rule strengthens its authority to recover Medicare payments, clarifies home palliative care access and accelerates public quality reporting, with savings expected in the tens of millions of dollars.

The Centers for Medicare & Medicaid Services (CMS) has finalised its calendar year 2027 Home Health final rule, announced on 4 November 2026. The agency presents the rule as a package of Medicare integrity measures.

According to CMS, the rule strengthens the agency's authority to recover Medicare payments. It also clarifies how patients can access palliative care in the home setting and speeds up the public reporting of home health quality information.

CMS expects the changes to save taxpayers tens of millions of dollars. The announcement, as available to VigiEye, gives no further detail on the mechanisms, effective dates or the specific provisions behind that estimate.

The rule is aimed chiefly at home health providers and at Medicare payment integrity. It has limited direct bearing on pharmacovigilance or medicinal product regulation.

What it means for your team

  • Home health providers and their advisers should review the full final rule text for the detail of the payment recovery provisions, which the announcement does not set out.
  • Market-access teams with home-based care or palliative services in their remit may wish to check the clarified palliative care access language.
  • Pharmacovigilance and drug regulatory teams are unlikely to need to act, as the announcement does not address medicines safety or product regulation.

Official source: CMS ↗

Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.

More Pharmacovigilance All →